Aurora Spine Corporation
ASG.VTSXVHealthcare● Active
$0.23
+$0.00(+0.00%)
Market Cap$17961206
P/E Ratio—
52W High$0.355
52W Low$0.205
Aurora Spine Corporation（ASG.V）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ASG.V · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.74M) | ($1.00M) | ($1.68M) | ($1.50M) | ($2.36M) |
| Depreciation & Amort. | $0.00M | $1.01M | $1.05M | $0.87M | $0.65M |
| Stock-Based Comp. | $0.00M | $0.10M | $0.14M | $0.14M | $0.14M |
| Change in Working Capital | $0.22M | $0.62M | ($0.62M) | ($1.36M) | ($0.74M) |
| Net Cash from Operations | $0.93M | $0.90M | ($0.94M) | ($1.56M) | ($2.13M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.51M) | ($0.64M) | ($0.48M) | ($0.87M) | ($0.72M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.55M) | ($0.48M) | ($0.48M) | ($0.87M) | ($0.72M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.37M) | ($0.36M) | ($0.32M) | ($0.42M) | ($0.21M) |
| Net Cash from Financing | ($0.31M) | ($0.36M) | $1.76M | ($0.32M) | $4.31M |
| Free Cash Flow | |||||
| Free Cash Flow | $0.42M | $0.27M | ($1.41M) | ($2.43M) | ($2.85M) |
| FCF Margin %(computed) | 2.29% | 1.52% | -9.74% | -16.34% | -27.03% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Aurora Spine Corporation
关于Aurora Spine Corporation（ASG.V）现金流量表
Aurora Spine Corporation 2025财年经营活动现金流$0.00B，自由现金流$0.00B（FCF利润率2.29%），资本支出($0.00B)。
常见问题
ASG.V · 4 问Aurora Spine Corporation 2025财年自由现金流$0.00B，同比up57.6%。
ASG.V free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10